UBS Group’s SunLink Health Systems SSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-22,527
| Closed | -$19.8K | – | 10894 |
|
|
2025
Q2 | $19.8K | Sell |
22,527
-3,240
| -13% | -$2.94K | ﹤0.01% | 8449 |
|
|
2025
Q1 | $25.8K | Buy |
25,767
+12,504
| +94% | +$11.9K | ﹤0.01% | 8049 |
|
|
2024
Q4 | $11.7K | Buy |
+13,263
| New | +$11K | ﹤0.01% | 8232 |
|
|
2024
Q3 | – | Sell |
-1,541
| Closed | -$1.23K | – | 10038 |
|
|
2024
Q2 | $1.23K | Sell |
1,541
-8,535
| -85% | -$5.8K | ﹤0.01% | 8621 |
|
|
2024
Q1 | $7.36K | Buy |
+10,076
| New | +$8.58K | ﹤0.01% | 7390 |
|
|
2023
Q4 | – | Sell |
-4,526
| Closed | -$3.62K | – | 9855 |
|
|
2023
Q3 | $3.62K | Buy |
+4,526
| New | +$4.18K | ﹤0.01% | 7533 |
|
|
2023
Q2 | – | Sell |
-100
| Closed | -$110 | – | 9605 |
|
|
2023
Q1 | $110 | Buy |
+100
| New | +$98 | ﹤0.01% | 9226 |
|
|
2022
Q4 | – | Sell |
-5,709
| Closed | -$6K | – | 11129 |
|
|
2022
Q3 | $6K | Buy |
5,709
+1,210
| +27% | +$1.39K | ﹤0.01% | 9063 |
|
|
2022
Q2 | $5K | Buy |
4,499
+1,673
| +59% | +$1.95K | ﹤0.01% | 8932 |
|
|
2022
Q1 | $4K | Sell |
2,826
-2,225
| -44% | -$3.13K | ﹤0.01% | 9322 |
|
|
2021
Q4 | $8K | Buy |
5,051
+4,558
| +925% | +$10K | ﹤0.01% | 9057 |
|
|
2021
Q3 | $1K | Buy |
493
+394
| +398% | +$1.01K | ﹤0.01% | 9241 |
|
|
2021
Q2 | $0 | Buy |
+99
| New | +$282 | ﹤0.01% | 9797 |
|
|
2021
Q1 | – | Sell |
-1,132
| Closed | -$1K | – | 9439 |
|
|
2020
Q4 | $1K | Sell |
1,132
-1,205
| -52% | -$1.4K | ﹤0.01% | 8250 |
|
|
2020
Q3 | $2K | Buy |
2,337
+1,965
| +528% | +$1.88K | ﹤0.01% | 7689 |
|
|
2020
Q2 | $0 | Sell |
372
-453
| -55% | -$356 | ﹤0.01% | 8337 |
|
|
2020
Q1 | $1K | Sell |
825
-2,377
| -74% | -$2.56K | ﹤0.01% | 7800 |
|
|
2019
Q4 | $3K | Buy |
3,202
+990
| +45% | +$1.14K | ﹤0.01% | 7764 |
|
|
2019
Q3 | $2K | Sell |
2,212
-1,076
| -33% | -$1.55K | ﹤0.01% | 7749 |
|
|
2019
Q2 | $5K | Sell |
3,288
-1,094
| -25% | -$1.68K | ﹤0.01% | 7391 |
|
|
2019
Q1 | $7K | Buy |
4,382
+2,618
| +148% | +$3.48K | ﹤0.01% | 7020 |
|
|
2018
Q4 | $2K | Buy |
+1,764
| New | +$2.07K | ﹤0.01% | 7817 |
|
|
2018
Q2 | – | Sell |
-1,791
| Closed | -$2K | – | 8228 |
|
|
2018
Q1 | $2K | Buy |
1,791
+591
| +49% | +$881 | ﹤0.01% | 7552 |
|
|
2017
Q4 | $2K | Sell |
1,200
-6,088
| -84% | -$9.4K | ﹤0.01% | 7626 |
|
|
2017
Q3 | $11K | Buy |
+7,288
| New | +$11.5K | ﹤0.01% | 6836 |
|
|
2017
Q2 | – | Sell |
-4,208
| Closed | -$7K | – | 7966 |
|
|
2017
Q1 | $7K | Buy |
+4,208
| New | +$6.4K | ﹤0.01% | 6828 |
|
|
2015
Q2 | – | Sell |
-3,861
| Closed | -$7K | – | 8797 |
|
|
2015
Q1 | $7K | Buy |
+3,861
| New | +$5.63K | ﹤0.01% | 7920 |
|
UBS Group's SSY Position: Q3 2025 in Review
UBS Group sold out of SunLink Health Systems (SSY) in Q3 2025, closing a stake of 22,527 shares — an estimated $19.8K sold.
UBS Group first reported a position in SSY in Q1 2015 and held it in 27 quarters. The position peaked at $25.8K in Q1 2025. 0 funds tracked by Wall St. Rank hold SSY as of Q3 2025.
- UBS Group reported no remaining SunLink Health Systems position as of Q3 2025 after selling out during the quarter.
- UBS Group sold 22,527 SunLink Health Systems shares in Q3 2025, an estimated $19.8K.
- UBS Group first reported a position in SunLink Health Systems in Q1 2015 and held it in 27 quarters.
- UBS Group's SunLink Health Systems position peaked at $25.8K in Q1 2025.
- 0 funds tracked by Wall St. Rank held SunLink Health Systems as of Q3 2025.
Based on UBS Group's 13F filing for Q3 2025, filed 13 Nov 2025.